Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Cross Country Healthcare management to meet virtually with Barrington » 04:55
12/14/22
12/14
04:55
12/14/22
04:55
CCRN

Cross Country Healthcare

$28.49 /

-1.065 (-3.60%)

Virtual Meeting to be…

Virtual Meeting to be held on December 14 hosted by Barrington.

ShowHide Related Items >><<
CCRN Cross Country Healthcare
$28.49 /

-1.065 (-3.60%)

CCRN Cross Country Healthcare
$28.49 /

-1.065 (-3.60%)

11/07/22 Barrington
Cross Country Healthcare price target raised to $45 from $41 at Barrington
10/05/22 Truist
Cross Country Healthcare downgraded to Hold at Truist on valuation
10/05/22 Truist
Cross Country Healthcare downgraded to Hold from Buy at Truist
09/15/22 Benchmark
Cross Country Healthcare price target raised to $42 from $37 at Benchmark
CCRN Cross Country Healthcare
$28.49 /

-1.065 (-3.60%)

CCRN Cross Country Healthcare
$28.49 /

-1.065 (-3.60%)

Hot Stocks
Cross Country Healthcare completes acquisition of Hireup Leadership » 16:16
12/13/22
12/13
16:16
12/13/22
16:16
CCRN

Cross Country Healthcare

$28.49 /

-1.065 (-3.60%)

Cross Country Healthcare…

Cross Country Healthcare "announced the acquisition of Hireup Leadership Inc. Hireup partners with organizations, including hospitals, academic medical centers, and clinics, to recruit healthcare leaders within nursing, allied, physician, human resources, and finance."

ShowHide Related Items >><<
CCRN Cross Country Healthcare
$28.49 /

-1.065 (-3.60%)

CCRN Cross Country Healthcare
$28.49 /

-1.065 (-3.60%)

11/07/22 Barrington
Cross Country Healthcare price target raised to $45 from $41 at Barrington
10/05/22 Truist
Cross Country Healthcare downgraded to Hold at Truist on valuation
10/05/22 Truist
Cross Country Healthcare downgraded to Hold from Buy at Truist
09/15/22 Benchmark
Cross Country Healthcare price target raised to $42 from $37 at Benchmark
CCRN Cross Country Healthcare
$28.49 /

-1.065 (-3.60%)

CCRN Cross Country Healthcare
$28.49 /

-1.065 (-3.60%)

Conference/Events
Cross Country Healthcare management to meet with Jefferies » 16:25
12/06/22
12/06
16:25
12/06/22
16:25
CCRN

Cross Country Healthcare

$33.49 /

-1.36 (-3.90%)

Analyst Tanquilut to hold…

Analyst Tanquilut to hold a group dinner meeting in New York on December 6 at 6 pm hosted by Jefferies.

ShowHide Related Items >><<
CCRN Cross Country Healthcare
$33.49 /

-1.36 (-3.90%)

CCRN Cross Country Healthcare
$33.49 /

-1.36 (-3.90%)

11/07/22 Barrington
Cross Country Healthcare price target raised to $45 from $41 at Barrington
10/05/22 Truist
Cross Country Healthcare downgraded to Hold at Truist on valuation
10/05/22 Truist
Cross Country Healthcare downgraded to Hold from Buy at Truist
09/15/22 Benchmark
Cross Country Healthcare price target raised to $42 from $37 at Benchmark
CCRN Cross Country Healthcare
$33.49 /

-1.36 (-3.90%)

CCRN Cross Country Healthcare
$33.49 /

-1.36 (-3.90%)

Conference/Events
Cross Country Healthcare management to meet virtually with Barrington » 13:00
12/06/22
12/06
13:00
12/06/22
13:00
CCRN

Cross Country Healthcare

$34.16 /

-0.69 (-1.98%)

Virtual Meeting to be…

Virtual Meeting to be held on December 14 hosted by Barrington.

ShowHide Related Items >><<
CCRN Cross Country Healthcare
$34.16 /

-0.69 (-1.98%)

CCRN Cross Country Healthcare
$34.16 /

-0.69 (-1.98%)

11/07/22 Barrington
Cross Country Healthcare price target raised to $45 from $41 at Barrington
10/05/22 Truist
Cross Country Healthcare downgraded to Hold at Truist on valuation
10/05/22 Truist
Cross Country Healthcare downgraded to Hold from Buy at Truist
09/15/22 Benchmark
Cross Country Healthcare price target raised to $42 from $37 at Benchmark
CCRN Cross Country Healthcare
$34.16 /

-0.69 (-1.98%)

CCRN Cross Country Healthcare
$34.16 /

-0.69 (-1.98%)

Conference/Events
Cross Country Healthcare management to meet with Jefferies » 12:24
12/06/22
12/06
12:24
12/06/22
12:24
CCRN

Cross Country Healthcare

$34.34 /

-0.51 (-1.46%)

Analyst Tanquilut to hold…

Analyst Tanquilut to hold a group dinner meeting in New York on December 6 at 6 pm hosted by Jefferies.

ShowHide Related Items >><<
CCRN Cross Country Healthcare
$34.34 /

-0.51 (-1.46%)

CCRN Cross Country Healthcare
$34.34 /

-0.51 (-1.46%)

11/07/22 Barrington
Cross Country Healthcare price target raised to $45 from $41 at Barrington
10/05/22 Truist
Cross Country Healthcare downgraded to Hold at Truist on valuation
10/05/22 Truist
Cross Country Healthcare downgraded to Hold from Buy at Truist
09/15/22 Benchmark
Cross Country Healthcare price target raised to $42 from $37 at Benchmark
CCRN Cross Country Healthcare
$34.34 /

-0.51 (-1.46%)

CCRN Cross Country Healthcare
$34.34 /

-0.51 (-1.46%)

Conference/Events
Credit Suisse to hold a conference » 04:55
11/10/22
11/10
04:55
11/10/22
04:55
ABSI

Absci

$3.20 /

+0.14 (+4.58%)

, CYH

Community Health

$2.69 /

-0.355 (-11.66%)

, IQV

Iqvia

$204.37 /

-3.46 (-1.66%)

, RNA

Avidity Biosciences

$14.01 /

+0.45 (+3.32%)

, ROIV

Roivant Sciences

$5.07 /

+0.055 (+1.10%)

, JNJ

Johnson & Johnson

$172.50 /

-1.35 (-0.78%)

, KMDA

Kamada

$4.27 /

-0.06 (-1.39%)

, MGTA

Magenta Therapeutics

$1.09 /

-0.08 (-6.84%)

, STRO

Sutro Biopharma

$7.37 /

+0.225 (+3.15%)

, THC

Tenet Healthcare

$38.32 /

-2.145 (-5.30%)

, TNDM

TNDM

/

+

, TOI

The Oncology Institute

$3.10 /

-0.07 (-2.21%)

, UTHR

United Therapeutics

$264.69 /

+1.82 (+0.69%)

, CCRN

Cross Country Healthcare

$33.24 /

-0.755 (-2.22%)

, FULC

Fulcrum Therapeutics

$6.98 /

+0.53 (+8.22%)

, CADL

Candel Therapeutics

$1.51 /

-0.04 (-2.58%)

, BIO

Bio-Rad

$404.17 /

+23.57 (+6.19%)

, AMWL

Amwell

$3.65 /

+0.115 (+3.25%)

, CGEM

Cullinan Oncology

$11.60 /

-0.72 (-5.84%)

, GLUE

Monte Rosa Therapeutics

$7.62 /

-0.24 (-3.05%)

31st Annual Healthcare…

31st Annual Healthcare Conference to be held in Rancho Palos Verdes, CA on November 7-10.

ShowHide Related Items >><<
UTHR United Therapeutics
$264.69 /

+1.82 (+0.69%)

TOI The Oncology Institute
$3.10 /

-0.07 (-2.21%)

TNDM TNDM
/

+

THC Tenet Healthcare
$38.32 /

-2.145 (-5.30%)

STRO Sutro Biopharma
$7.37 /

+0.225 (+3.15%)

ROIV Roivant Sciences
$5.07 /

+0.055 (+1.10%)

RNA Avidity Biosciences
$14.01 /

+0.45 (+3.32%)

MGTA Magenta Therapeutics
$1.09 /

-0.08 (-6.84%)

KMDA Kamada
$4.27 /

-0.06 (-1.39%)

JNJ Johnson & Johnson
$172.50 /

-1.35 (-0.78%)

IQV Iqvia
$204.37 /

-3.46 (-1.66%)

GLUE Monte Rosa Therapeutics
$7.62 /

-0.24 (-3.05%)

FULC Fulcrum Therapeutics
$6.98 /

+0.53 (+8.22%)

CYH Community Health
$2.69 /

-0.355 (-11.66%)

CGEM Cullinan Oncology
$11.60 /

-0.72 (-5.84%)

CCRN Cross Country Healthcare
$33.24 /

-0.755 (-2.22%)

CADL Candel Therapeutics
$1.51 /

-0.04 (-2.58%)

BIO Bio-Rad
$404.17 /

+23.57 (+6.19%)

AMWL Amwell
$3.65 /

+0.115 (+3.25%)

ABSI Absci
$3.20 /

+0.14 (+4.58%)

ABSI Absci
$3.20 /

+0.14 (+4.58%)

08/12/22 JPMorgan
Absci double downgraded to Underweight at JPMorgan on slower revenue ramp
08/12/22 JPMorgan
Absci downgraded to Underweight from Overweight at JPMorgan
08/12/22 Cowen
Absci upgraded to Outperform from Market Perform at Cowen
07/18/22 Truist
Truist starts Absci at Buy on confluence of biotech, next-gen biologics
CYH Community Health
$2.69 /

-0.355 (-11.66%)

08/04/22 Citi
Community Health price target lowered to $6 from $14 at Citi
07/29/22 Oppenheimer
Community Health price target lowered to $6 from $16 at Oppenheimer
06/16/22 Loop Capital
Loop starts Community Health at Hold amid labor challenges
06/16/22 Loop Capital
Community Health initiated with a Hold at Loop Capital
IQV Iqvia
$204.37 /

-3.46 (-1.66%)

10/27/22 Credit Suisse
Iqvia price target lowered to $265 from $300 at Credit Suisse
10/27/22 Citi
Iqvia price target lowered to $275 from $290 at Citi
10/27/22 Barclays
Iqvia price target raised to $235 from $215 at Barclays
10/18/22 Deutsche Bank
Iqvia price target lowered to $270 from $290 at Deutsche Bank
RNA Avidity Biosciences
$14.01 /

+0.45 (+3.32%)

09/27/22 Chardan
Avidity Biosciences price target lowered to $27 from $29 at Chardan
07/20/22 Chardan
Avidity Biosciences initiated with a Buy at Chardan
07/11/22 Raymond James
Avidity Biosciences initiated with a Strong Buy at Raymond James
ROIV Roivant Sciences
$5.07 /

+0.055 (+1.10%)

10/27/22 JPMorgan
Roivant Sciences initiated with an Overweight at JPMorgan
08/16/22 Citi
Roivant Sciences price target raised to $10 from $9 at Citi
05/23/22 SVB Securities
Roivant Sciences initiated with an Outperform at SVB Leerink
04/29/22 Cantor Fitzgerald
Roivant Sciences initiated with an Overweight at Cantor Fitzgerald
JNJ Johnson & Johnson
$172.50 /

-1.35 (-0.78%)

11/02/22 Morgan Stanley
Abiomed upgraded to Equal Weight from Underweight at Morgan Stanley
11/02/22 Deutsche Bank
Abiomed downgraded to Hold from Buy at Deutsche Bank
11/01/22 Piper Sandler
Abiomed downgraded to Neutral from Overweight at Piper Sandler
11/01/22 Cowen
Cowen starts Legend Biotech with an Outperform on Carvykti potential
KMDA Kamada
$4.27 /

-0.06 (-1.39%)

MGTA Magenta Therapeutics
$1.09 /

-0.08 (-6.84%)

08/24/22 Goldman Sachs
Magenta downgraded on limited clinical catalysts at Goldman Sachs
08/24/22 Goldman Sachs
Magenta Therapeutics downgraded to Neutral from Buy at Goldman Sachs
04/18/22 Mizuho
Magenta Therapeutics price target lowered to $8 from $17 at Mizuho
04/18/22 BTIG
Magenta Therapeutics price target lowered to $6 from $10 at BTIG
STRO Sutro Biopharma
$7.37 /

+0.225 (+3.15%)

11/09/22 H.C. Wainwright
Sutro Biopharma price target lowered to $20 from $30 at H.C. Wainwright
08/23/22 Truist
Sutro Biopharma price target lowered to $21 from $37 at Truist
08/18/22 Wells Fargo
Sutro Biopharma assumed with an Overweight at Wells Fargo
06/28/22 Piper Sandler
Sutro Biopharma price target raised to $16 from $14 at Piper Sandler
THC Tenet Healthcare
$38.32 /

-2.145 (-5.30%)

10/27/22 Raymond James
Tenet Healthcare price target lowered to $80 from $135 at Raymond James
10/25/22 Citi
Tenet Healthcare shares offer 'significant upside,' says Citi
10/24/22 Truist
Tenet Healthcare price target lowered to $55 from $80 at Truist
10/24/22 Deutsche Bank
Tenet Healthcare price target lowered to $48 from $90 at Deutsche Bank
TNDM TNDM
/

+

11/03/22 Lake Street
Tandem Diabetes price target lowered to $60 from $150 at Lake Street
11/03/22 Craig-Hallum
Tandem Diabetes price target lowered to $80 from $105 at Craig-Hallum
11/03/22 Cowen
Tandem Diabetes price target lowered to $61 from $107 at Cowen
11/03/22 Baird
Tandem Diabetes price target lowered to $45 from $76 at Baird
TOI The Oncology Institute
$3.10 /

-0.07 (-2.21%)

09/14/22 Guggenheim
The Oncology Institute initiated with a Buy at Guggenheim
08/15/22 Jefferies
The Oncology Institute initiated with a Buy at Jefferies
UTHR United Therapeutics
$264.69 /

+1.82 (+0.69%)

11/03/22 Wedbush
United Therapeutics price target raised to $305 from $250 at Wedbush
11/03/22 Oppenheimer
United Therapeutics price target raised to $375 from $325 at Oppenheimer
11/03/22 H.C. Wainwright
United Therapeutics price target raised to $300 from $255 at H.C. Wainwright
10/11/22 Morgan Stanley
United Therapeutics initiated with an Overweight at Morgan Stanley
CCRN Cross Country Healthcare
$33.24 /

-0.755 (-2.22%)

11/07/22 Barrington
Cross Country Healthcare price target raised to $45 from $41 at Barrington
10/05/22 Truist
Cross Country Healthcare downgraded to Hold at Truist on valuation
10/05/22 Truist
Cross Country Healthcare downgraded to Hold from Buy at Truist
09/15/22 Benchmark
Cross Country Healthcare price target raised to $42 from $37 at Benchmark
FULC Fulcrum Therapeutics
$6.98 /

+0.53 (+8.22%)

11/08/22 Piper Sandler
Fulcrum Therapeutics price target lowered to $18 from $42 at Piper Sandler
10/20/22 Stifel
Fulcrum Therapeutics price target lowered to $35 from $43 at Stifel
06/10/22 Piper Sandler
Fulcrum should be bought on today's selloff, says Piper Sandler
06/10/22 H.C. Wainwright
H.C. Wainwright says Fulcrum data 'raises multiple questions,' halves target
CADL Candel Therapeutics
$1.51 /

-0.04 (-2.58%)

03/31/22 BMO Capital
Candel Therapeutics price target lowered to $12 from $18 at BMO Capital
11/18/21 BMO Capital
Candel Therapeutics initiated with an Outperform at BMO Capital
BIO Bio-Rad
$404.17 /

+23.57 (+6.19%)

10/11/22 Jefferies
Jefferies 'not surprised' by report of Bio-Rad talks to combine with Qiagen
08/24/22 Credit Suisse
Bio-Rad initiated with an Outperform at Credit Suisse
07/08/22 Citi
Bio-Rad price target lowered to $700 from $750 at Citi
05/02/22 Citi
Bio-Rad price target lowered to $750 from $800 at Citi
AMWL Amwell
$3.65 /

+0.115 (+3.25%)

09/07/22 Truist
Amwell initiated with a Hold at Truist
09/07/22 Piper Sandler
Amwell price target lowered to $5 from $6 at Piper Sandler
06/23/22 Piper Sandler
Amwell price target raised to $6 from $5 at Piper Sandler
06/03/22 Morgan Stanley
CVS deal a 'game-changer' for Amwell's Converge, says Morgan Stanley
CGEM Cullinan Oncology
$11.60 /

-0.72 (-5.84%)

GLUE Monte Rosa Therapeutics
$7.62 /

-0.24 (-3.05%)

10/13/22 UBS
Monte Rosa Therapeutics initiated with a Buy at UBS
08/15/22 Jefferies
Monte Rosa Therapeutics initiated with a Buy at Jefferies
05/11/22 Piper Sandler
Monte Rosa Therapeutics price target lowered to $21 from $40 at Piper Sandler
04/28/22 Credit Suisse
Monte Rosa Therapeutics initiated with a Neutral at Credit Suisse
UTHR United Therapeutics
$264.69 /

+1.82 (+0.69%)

TOI The Oncology Institute
$3.10 /

-0.07 (-2.21%)

TNDM TNDM
/

+

THC Tenet Healthcare
$38.32 /

-2.145 (-5.30%)

STRO Sutro Biopharma
$7.37 /

+0.225 (+3.15%)

ROIV Roivant Sciences
$5.07 /

+0.055 (+1.10%)

RNA Avidity Biosciences
$14.01 /

+0.45 (+3.32%)

MGTA Magenta Therapeutics
$1.09 /

-0.08 (-6.84%)

KMDA Kamada
$4.27 /

-0.06 (-1.39%)

JNJ Johnson & Johnson
$172.50 /

-1.35 (-0.78%)

IQV Iqvia
$204.37 /

-3.46 (-1.66%)

GLUE Monte Rosa Therapeutics
$7.62 /

-0.24 (-3.05%)

FULC Fulcrum Therapeutics
$6.98 /

+0.53 (+8.22%)

CYH Community Health
$2.69 /

-0.355 (-11.66%)

CGEM Cullinan Oncology
$11.60 /

-0.72 (-5.84%)

CCRN Cross Country Healthcare
$33.24 /

-0.755 (-2.22%)

CADL Candel Therapeutics
$1.51 /

-0.04 (-2.58%)

BIO Bio-Rad
$404.17 /

+23.57 (+6.19%)

AMWL Amwell
$3.65 /

+0.115 (+3.25%)

ABSI Absci
$3.20 /

+0.14 (+4.58%)

  • 08
    Nov
  • 16
    Aug
  • 30
    Nov
JNJ Johnson & Johnson
$172.50 /

-1.35 (-0.78%)

IQV Iqvia
$204.37 /

-3.46 (-1.66%)

CYH Community Health
$2.69 /

-0.355 (-11.66%)

BIO Bio-Rad
$404.17 /

+23.57 (+6.19%)

AMWL Amwell
$3.65 /

+0.115 (+3.25%)

UTHR United Therapeutics
$264.69 /

+1.82 (+0.69%)

TOI The Oncology Institute
$3.10 /

-0.07 (-2.21%)

TNDM TNDM
/

+

THC Tenet Healthcare
$38.32 /

-2.145 (-5.30%)

STRO Sutro Biopharma
$7.37 /

+0.225 (+3.15%)

ROIV Roivant Sciences
$5.07 /

+0.055 (+1.10%)

RNA Avidity Biosciences
$14.01 /

+0.45 (+3.32%)

KMDA Kamada
$4.27 /

-0.06 (-1.39%)

JNJ Johnson & Johnson
$172.50 /

-1.35 (-0.78%)

FULC Fulcrum Therapeutics
$6.98 /

+0.53 (+8.22%)

CYH Community Health
$2.69 /

-0.355 (-11.66%)

CGEM Cullinan Oncology
$11.60 /

-0.72 (-5.84%)

CCRN Cross Country Healthcare
$33.24 /

-0.755 (-2.22%)

BIO Bio-Rad
$404.17 /

+23.57 (+6.19%)

AMWL Amwell
$3.65 /

+0.115 (+3.25%)

THC Tenet Healthcare
$38.32 /

-2.145 (-5.30%)

JNJ Johnson & Johnson
$172.50 /

-1.35 (-0.78%)

IQV Iqvia
$204.37 /

-3.46 (-1.66%)

GLUE Monte Rosa Therapeutics
$7.62 /

-0.24 (-3.05%)

Conference/Events
Credit Suisse to hold a conference » 04:55
11/09/22
11/09
04:55
11/09/22
04:55
ABSI

Absci

$3.06 /

+0.08 (+2.68%)

, CYH

Community Health

$3.05 /

+0.12 (+4.10%)

, IQV

Iqvia

$207.94 /

-0.05 (-0.02%)

, RNA

Avidity Biosciences

$13.56 /

+0.32 (+2.42%)

, ROIV

Roivant Sciences

$5.01 /

-0.625 (-11.09%)

, JNJ

Johnson & Johnson

$173.86 /

+0.895 (+0.52%)

, KMDA

Kamada

$4.33 /

+0.04 (+0.93%)

, MGTA

Magenta Therapeutics

$1.14 /

-0.04 (-3.39%)

, STRO

Sutro Biopharma

$7.14 /

-0.39 (-5.18%)

, THC

Tenet Healthcare

$40.51 /

-0.55 (-1.34%)

, TNDM

TNDM

/

+

, TOI

The Oncology Institute

$3.19 /

-0.075 (-2.30%)

, UTHR

United Therapeutics

$262.78 /

-5.73 (-2.13%)

, CCRN

Cross Country Healthcare

$33.97 /

+0.53 (+1.58%)

, FULC

Fulcrum Therapeutics

$6.45 /

+0.84 (+14.97%)

, CADL

Candel Therapeutics

$1.55 /

-0.3 (-16.22%)

, BIO

Bio-Rad

$380.66 /

+2.525 (+0.67%)

, AMWL

Amwell

$3.55 /

-0.09 (-2.48%)

, CGEM

Cullinan Oncology

$12.46 /

+0.18 (+1.47%)

, GLUE

Monte Rosa Therapeutics

$7.86 /

-0.38 (-4.61%)

31st Annual Healthcare…

31st Annual Healthcare Conference to be held in Rancho Palos Verdes, CA on November 7-10.

ShowHide Related Items >><<
UTHR United Therapeutics
$262.78 /

-5.73 (-2.13%)

TOI The Oncology Institute
$3.19 /

-0.075 (-2.30%)

TNDM TNDM
/

+

THC Tenet Healthcare
$40.51 /

-0.55 (-1.34%)

STRO Sutro Biopharma
$7.14 /

-0.39 (-5.18%)

ROIV Roivant Sciences
$5.01 /

-0.625 (-11.09%)

RNA Avidity Biosciences
$13.56 /

+0.32 (+2.42%)

MGTA Magenta Therapeutics
$1.14 /

-0.04 (-3.39%)

KMDA Kamada
$4.33 /

+0.04 (+0.93%)

JNJ Johnson & Johnson
$173.86 /

+0.895 (+0.52%)

IQV Iqvia
$207.94 /

-0.05 (-0.02%)

GLUE Monte Rosa Therapeutics
$7.86 /

-0.38 (-4.61%)

FULC Fulcrum Therapeutics
$6.45 /

+0.84 (+14.97%)

CYH Community Health
$3.05 /

+0.12 (+4.10%)

CGEM Cullinan Oncology
$12.46 /

+0.18 (+1.47%)

CCRN Cross Country Healthcare
$33.97 /

+0.53 (+1.58%)

CADL Candel Therapeutics
$1.55 /

-0.3 (-16.22%)

BIO Bio-Rad
$380.66 /

+2.525 (+0.67%)

AMWL Amwell
$3.55 /

-0.09 (-2.48%)

ABSI Absci
$3.06 /

+0.08 (+2.68%)

ABSI Absci
$3.06 /

+0.08 (+2.68%)

08/12/22 JPMorgan
Absci double downgraded to Underweight at JPMorgan on slower revenue ramp
08/12/22 JPMorgan
Absci downgraded to Underweight from Overweight at JPMorgan
08/12/22 Cowen
Absci upgraded to Outperform from Market Perform at Cowen
07/18/22 Truist
Truist starts Absci at Buy on confluence of biotech, next-gen biologics
CYH Community Health
$3.05 /

+0.12 (+4.10%)

08/04/22 Citi
Community Health price target lowered to $6 from $14 at Citi
07/29/22 Oppenheimer
Community Health price target lowered to $6 from $16 at Oppenheimer
06/16/22 Loop Capital
Loop starts Community Health at Hold amid labor challenges
06/16/22 Loop Capital
Community Health initiated with a Hold at Loop Capital
IQV Iqvia
$207.94 /

-0.05 (-0.02%)

10/27/22 Credit Suisse
Iqvia price target lowered to $265 from $300 at Credit Suisse
10/27/22 Citi
Iqvia price target lowered to $275 from $290 at Citi
10/27/22 Barclays
Iqvia price target raised to $235 from $215 at Barclays
10/18/22 Deutsche Bank
Iqvia price target lowered to $270 from $290 at Deutsche Bank
RNA Avidity Biosciences
$13.56 /

+0.32 (+2.42%)

09/27/22 Chardan
Avidity Biosciences price target lowered to $27 from $29 at Chardan
07/20/22 Chardan
Avidity Biosciences initiated with a Buy at Chardan
07/11/22 Raymond James
Avidity Biosciences initiated with a Strong Buy at Raymond James
ROIV Roivant Sciences
$5.01 /

-0.625 (-11.09%)

10/27/22 JPMorgan
Roivant Sciences initiated with an Overweight at JPMorgan
08/16/22 Citi
Roivant Sciences price target raised to $10 from $9 at Citi
05/23/22 SVB Securities
Roivant Sciences initiated with an Outperform at SVB Leerink
04/29/22 Cantor Fitzgerald
Roivant Sciences initiated with an Overweight at Cantor Fitzgerald
JNJ Johnson & Johnson
$173.86 /

+0.895 (+0.52%)

11/02/22 Morgan Stanley
Abiomed upgraded to Equal Weight from Underweight at Morgan Stanley
11/02/22 Deutsche Bank
Abiomed downgraded to Hold from Buy at Deutsche Bank
11/01/22 Piper Sandler
Abiomed downgraded to Neutral from Overweight at Piper Sandler
11/01/22 Cowen
Cowen starts Legend Biotech with an Outperform on Carvykti potential
KMDA Kamada
$4.33 /

+0.04 (+0.93%)

MGTA Magenta Therapeutics
$1.14 /

-0.04 (-3.39%)

08/24/22 Goldman Sachs
Magenta downgraded on limited clinical catalysts at Goldman Sachs
08/24/22 Goldman Sachs
Magenta Therapeutics downgraded to Neutral from Buy at Goldman Sachs
04/18/22 Mizuho
Magenta Therapeutics price target lowered to $8 from $17 at Mizuho
04/18/22 BTIG
Magenta Therapeutics price target lowered to $6 from $10 at BTIG
STRO Sutro Biopharma
$7.14 /

-0.39 (-5.18%)

08/23/22 Truist
Sutro Biopharma price target lowered to $21 from $37 at Truist
08/18/22 Wells Fargo
Sutro Biopharma assumed with an Overweight at Wells Fargo
06/28/22 Piper Sandler
Sutro Biopharma price target raised to $16 from $14 at Piper Sandler
05/23/22 Piper Sandler
Sutro Biopharma price target lowered to $14 from $29 at Piper Sandler
THC Tenet Healthcare
$40.51 /

-0.55 (-1.34%)

10/27/22 Raymond James
Tenet Healthcare price target lowered to $80 from $135 at Raymond James
10/25/22 Citi
Tenet Healthcare shares offer 'significant upside,' says Citi
10/24/22 Truist
Tenet Healthcare price target lowered to $55 from $80 at Truist
10/24/22 Deutsche Bank
Tenet Healthcare price target lowered to $48 from $90 at Deutsche Bank
TNDM TNDM
/

+

11/03/22 Lake Street
Tandem Diabetes price target lowered to $60 from $150 at Lake Street
11/03/22 Craig-Hallum
Tandem Diabetes price target lowered to $80 from $105 at Craig-Hallum
11/03/22 Cowen
Tandem Diabetes price target lowered to $61 from $107 at Cowen
11/03/22 Baird
Tandem Diabetes price target lowered to $45 from $76 at Baird
TOI The Oncology Institute
$3.19 /

-0.075 (-2.30%)

09/14/22 Guggenheim
The Oncology Institute initiated with a Buy at Guggenheim
08/15/22 Jefferies
The Oncology Institute initiated with a Buy at Jefferies
UTHR United Therapeutics
$262.78 /

-5.73 (-2.13%)

11/03/22 Wedbush
United Therapeutics price target raised to $305 from $250 at Wedbush
11/03/22 Oppenheimer
United Therapeutics price target raised to $375 from $325 at Oppenheimer
11/03/22 H.C. Wainwright
United Therapeutics price target raised to $300 from $255 at H.C. Wainwright
10/11/22 Morgan Stanley
United Therapeutics initiated with an Overweight at Morgan Stanley
CCRN Cross Country Healthcare
$33.97 /

+0.53 (+1.58%)

11/07/22 Barrington
Cross Country Healthcare price target raised to $45 from $41 at Barrington
10/05/22 Truist
Cross Country Healthcare downgraded to Hold at Truist on valuation
10/05/22 Truist
Cross Country Healthcare downgraded to Hold from Buy at Truist
09/15/22 Benchmark
Cross Country Healthcare price target raised to $42 from $37 at Benchmark
FULC Fulcrum Therapeutics
$6.45 /

+0.84 (+14.97%)

11/08/22 Piper Sandler
Fulcrum Therapeutics price target lowered to $18 from $42 at Piper Sandler
10/20/22 Stifel
Fulcrum Therapeutics price target lowered to $35 from $43 at Stifel
06/10/22 Piper Sandler
Fulcrum should be bought on today's selloff, says Piper Sandler
06/10/22 H.C. Wainwright
H.C. Wainwright says Fulcrum data 'raises multiple questions,' halves target
CADL Candel Therapeutics
$1.55 /

-0.3 (-16.22%)

03/31/22 BMO Capital
Candel Therapeutics price target lowered to $12 from $18 at BMO Capital
11/18/21 BMO Capital
Candel Therapeutics initiated with an Outperform at BMO Capital
BIO Bio-Rad
$380.66 /

+2.525 (+0.67%)

10/11/22 Jefferies
Jefferies 'not surprised' by report of Bio-Rad talks to combine with Qiagen
08/24/22 Credit Suisse
Bio-Rad initiated with an Outperform at Credit Suisse
07/08/22 Citi
Bio-Rad price target lowered to $700 from $750 at Citi
05/02/22 Citi
Bio-Rad price target lowered to $750 from $800 at Citi
AMWL Amwell
$3.55 /

-0.09 (-2.48%)

09/07/22 Truist
Amwell initiated with a Hold at Truist
09/07/22 Piper Sandler
Amwell price target lowered to $5 from $6 at Piper Sandler
06/23/22 Piper Sandler
Amwell price target raised to $6 from $5 at Piper Sandler
06/03/22 Morgan Stanley
CVS deal a 'game-changer' for Amwell's Converge, says Morgan Stanley
CGEM Cullinan Oncology
$12.46 /

+0.18 (+1.47%)

GLUE Monte Rosa Therapeutics
$7.86 /

-0.38 (-4.61%)

10/13/22 UBS
Monte Rosa Therapeutics initiated with a Buy at UBS
08/15/22 Jefferies
Monte Rosa Therapeutics initiated with a Buy at Jefferies
05/11/22 Piper Sandler
Monte Rosa Therapeutics price target lowered to $21 from $40 at Piper Sandler
04/28/22 Credit Suisse
Monte Rosa Therapeutics initiated with a Neutral at Credit Suisse
UTHR United Therapeutics
$262.78 /

-5.73 (-2.13%)

TOI The Oncology Institute
$3.19 /

-0.075 (-2.30%)

TNDM TNDM
/

+

THC Tenet Healthcare
$40.51 /

-0.55 (-1.34%)

STRO Sutro Biopharma
$7.14 /

-0.39 (-5.18%)

ROIV Roivant Sciences
$5.01 /

-0.625 (-11.09%)

RNA Avidity Biosciences
$13.56 /

+0.32 (+2.42%)

MGTA Magenta Therapeutics
$1.14 /

-0.04 (-3.39%)

KMDA Kamada
$4.33 /

+0.04 (+0.93%)

JNJ Johnson & Johnson
$173.86 /

+0.895 (+0.52%)

IQV Iqvia
$207.94 /

-0.05 (-0.02%)

GLUE Monte Rosa Therapeutics
$7.86 /

-0.38 (-4.61%)

FULC Fulcrum Therapeutics
$6.45 /

+0.84 (+14.97%)

CYH Community Health
$3.05 /

+0.12 (+4.10%)

CGEM Cullinan Oncology
$12.46 /

+0.18 (+1.47%)

CCRN Cross Country Healthcare
$33.97 /

+0.53 (+1.58%)

CADL Candel Therapeutics
$1.55 /

-0.3 (-16.22%)

BIO Bio-Rad
$380.66 /

+2.525 (+0.67%)

AMWL Amwell
$3.55 /

-0.09 (-2.48%)

ABSI Absci
$3.06 /

+0.08 (+2.68%)

  • 08
    Nov
  • 16
    Aug
  • 30
    Nov
JNJ Johnson & Johnson
$173.86 /

+0.895 (+0.52%)

IQV Iqvia
$207.94 /

-0.05 (-0.02%)

CYH Community Health
$3.05 /

+0.12 (+4.10%)

BIO Bio-Rad
$380.66 /

+2.525 (+0.67%)

AMWL Amwell
$3.55 /

-0.09 (-2.48%)

UTHR United Therapeutics
$262.78 /

-5.73 (-2.13%)

TOI The Oncology Institute
$3.19 /

-0.075 (-2.30%)

TNDM TNDM
/

+

THC Tenet Healthcare
$40.51 /

-0.55 (-1.34%)

STRO Sutro Biopharma
$7.14 /

-0.39 (-5.18%)

ROIV Roivant Sciences
$5.01 /

-0.625 (-11.09%)

RNA Avidity Biosciences
$13.56 /

+0.32 (+2.42%)

KMDA Kamada
$4.33 /

+0.04 (+0.93%)

JNJ Johnson & Johnson
$173.86 /

+0.895 (+0.52%)

FULC Fulcrum Therapeutics
$6.45 /

+0.84 (+14.97%)

CYH Community Health
$3.05 /

+0.12 (+4.10%)

CGEM Cullinan Oncology
$12.46 /

+0.18 (+1.47%)

CCRN Cross Country Healthcare
$33.97 /

+0.53 (+1.58%)

BIO Bio-Rad
$380.66 /

+2.525 (+0.67%)

AMWL Amwell
$3.55 /

-0.09 (-2.48%)

THC Tenet Healthcare
$40.51 /

-0.55 (-1.34%)

JNJ Johnson & Johnson
$173.86 /

+0.895 (+0.52%)

IQV Iqvia
$207.94 /

-0.05 (-0.02%)

GLUE Monte Rosa Therapeutics
$7.86 /

-0.38 (-4.61%)

Conference/Events
Credit Suisse to hold a conference » 04:55
11/08/22
11/08
04:55
11/08/22
04:55
ABSI

Absci

$2.98 /

+0.07 (+2.41%)

, CYH

Community Health

$2.93 /

-0.015 (-0.51%)

, IQV

Iqvia

$207.99 /

+3.96 (+1.94%)

, RNA

Avidity Biosciences

$13.24 /

-0.305 (-2.25%)

, ROIV

Roivant Sciences

$5.62 /

+0.12 (+2.18%)

, JNJ

Johnson & Johnson

$173.05 /

+1.74 (+1.02%)

, KMDA

Kamada

$4.33 /

-0.05 (-1.14%)

, MGTA

Magenta Therapeutics

$1.21 /

+0.01 (+0.83%)

, STRO

Sutro Biopharma

$7.52 /

+0.17 (+2.31%)

, THC

Tenet Healthcare

$41.06 /

-0.7 (-1.68%)

, TNDM

TNDM

/

+

, TOI

The Oncology Institute

$3.27 /

-0.095 (-2.83%)

, UTHR

United Therapeutics

$266.76 /

+1.805 (+0.68%)

, CCRN

Cross Country Healthcare

$33.47 /

+1.05 (+3.24%)

, FULC

Fulcrum Therapeutics

$5.61 /

-0.145 (-2.52%)

, CADL

Candel Therapeutics

$1.74 /

+0.17 (+10.86%)

, BIO

Bio-Rad

$378.95 /

+1.42 (+0.38%)

, AMWL

Amwell

$3.64 /

+0.025 (+0.69%)

, CGEM

Cullinan Oncology

$12.22 /

-0.2 (-1.61%)

, GLUE

Monte Rosa Therapeutics

$8.24 /

+0.015 (+0.18%)

31st Annual Healthcare…

31st Annual Healthcare Conference to be held in Rancho Palos Verdes, CA on November 7-10.

ShowHide Related Items >><<
UTHR United Therapeutics
$266.76 /

+1.805 (+0.68%)

TOI The Oncology Institute
$3.27 /

-0.095 (-2.83%)

TNDM TNDM
/

+

THC Tenet Healthcare
$41.06 /

-0.7 (-1.68%)

STRO Sutro Biopharma
$7.52 /

+0.17 (+2.31%)

ROIV Roivant Sciences
$5.62 /

+0.12 (+2.18%)

RNA Avidity Biosciences
$13.24 /

-0.305 (-2.25%)

MGTA Magenta Therapeutics
$1.21 /

+0.01 (+0.83%)

KMDA Kamada
$4.33 /

-0.05 (-1.14%)

JNJ Johnson & Johnson
$173.05 /

+1.74 (+1.02%)

IQV Iqvia
$207.99 /

+3.96 (+1.94%)

GLUE Monte Rosa Therapeutics
$8.24 /

+0.015 (+0.18%)

FULC Fulcrum Therapeutics
$5.61 /

-0.145 (-2.52%)

CYH Community Health
$2.93 /

-0.015 (-0.51%)

CGEM Cullinan Oncology
$12.22 /

-0.2 (-1.61%)

CCRN Cross Country Healthcare
$33.47 /

+1.05 (+3.24%)

CADL Candel Therapeutics
$1.74 /

+0.17 (+10.86%)

BIO Bio-Rad
$378.95 /

+1.42 (+0.38%)

AMWL Amwell
$3.64 /

+0.025 (+0.69%)

ABSI Absci
$2.98 /

+0.07 (+2.41%)

ABSI Absci
$2.98 /

+0.07 (+2.41%)

08/12/22 JPMorgan
Absci double downgraded to Underweight at JPMorgan on slower revenue ramp
08/12/22 JPMorgan
Absci downgraded to Underweight from Overweight at JPMorgan
08/12/22 Cowen
Absci upgraded to Outperform from Market Perform at Cowen
07/18/22 Truist
Truist starts Absci at Buy on confluence of biotech, next-gen biologics
CYH Community Health
$2.93 /

-0.015 (-0.51%)

08/04/22 Citi
Community Health price target lowered to $6 from $14 at Citi
07/29/22 Oppenheimer
Community Health price target lowered to $6 from $16 at Oppenheimer
06/16/22 Loop Capital
Loop starts Community Health at Hold amid labor challenges
06/16/22 Loop Capital
Community Health initiated with a Hold at Loop Capital
IQV Iqvia
$207.99 /

+3.96 (+1.94%)

10/27/22 Credit Suisse
Iqvia price target lowered to $265 from $300 at Credit Suisse
10/27/22 Citi
Iqvia price target lowered to $275 from $290 at Citi
10/27/22 Barclays
Iqvia price target raised to $235 from $215 at Barclays
10/18/22 Deutsche Bank
Iqvia price target lowered to $270 from $290 at Deutsche Bank
RNA Avidity Biosciences
$13.24 /

-0.305 (-2.25%)

09/27/22 Chardan
Avidity Biosciences price target lowered to $27 from $29 at Chardan
07/20/22 Chardan
Avidity Biosciences initiated with a Buy at Chardan
07/11/22 Raymond James
Avidity Biosciences initiated with a Strong Buy at Raymond James
ROIV Roivant Sciences
$5.62 /

+0.12 (+2.18%)

10/27/22 JPMorgan
Roivant Sciences initiated with an Overweight at JPMorgan
08/16/22 Citi
Roivant Sciences price target raised to $10 from $9 at Citi
05/23/22 SVB Securities
Roivant Sciences initiated with an Outperform at SVB Leerink
04/29/22 Cantor Fitzgerald
Roivant Sciences initiated with an Overweight at Cantor Fitzgerald
JNJ Johnson & Johnson
$173.05 /

+1.74 (+1.02%)

11/02/22 Morgan Stanley
Abiomed upgraded to Equal Weight from Underweight at Morgan Stanley
11/02/22 Deutsche Bank
Abiomed downgraded to Hold from Buy at Deutsche Bank
11/01/22 Piper Sandler
Abiomed downgraded to Neutral from Overweight at Piper Sandler
11/01/22 Cowen
Cowen starts Legend Biotech with an Outperform on Carvykti potential
KMDA Kamada
$4.33 /

-0.05 (-1.14%)

MGTA Magenta Therapeutics
$1.21 /

+0.01 (+0.83%)

08/24/22 Goldman Sachs
Magenta downgraded on limited clinical catalysts at Goldman Sachs
08/24/22 Goldman Sachs
Magenta Therapeutics downgraded to Neutral from Buy at Goldman Sachs
04/18/22 Mizuho
Magenta Therapeutics price target lowered to $8 from $17 at Mizuho
04/18/22 BTIG
Magenta Therapeutics price target lowered to $6 from $10 at BTIG
STRO Sutro Biopharma
$7.52 /

+0.17 (+2.31%)

08/23/22 Truist
Sutro Biopharma price target lowered to $21 from $37 at Truist
08/18/22 Wells Fargo
Sutro Biopharma assumed with an Overweight at Wells Fargo
06/28/22 Piper Sandler
Sutro Biopharma price target raised to $16 from $14 at Piper Sandler
05/23/22 Piper Sandler
Sutro Biopharma price target lowered to $14 from $29 at Piper Sandler
THC Tenet Healthcare
$41.06 /

-0.7 (-1.68%)

10/27/22 Raymond James
Tenet Healthcare price target lowered to $80 from $135 at Raymond James
10/25/22 Citi
Tenet Healthcare shares offer 'significant upside,' says Citi
10/24/22 Truist
Tenet Healthcare price target lowered to $55 from $80 at Truist
10/24/22 Deutsche Bank
Tenet Healthcare price target lowered to $48 from $90 at Deutsche Bank
TNDM TNDM
/

+

11/03/22 Lake Street
Tandem Diabetes price target lowered to $60 from $150 at Lake Street
11/03/22 Craig-Hallum
Tandem Diabetes price target lowered to $80 from $105 at Craig-Hallum
11/03/22 Cowen
Tandem Diabetes price target lowered to $61 from $107 at Cowen
11/03/22 Baird
Tandem Diabetes price target lowered to $45 from $76 at Baird
TOI The Oncology Institute
$3.27 /

-0.095 (-2.83%)

09/14/22 Guggenheim
The Oncology Institute initiated with a Buy at Guggenheim
08/15/22 Jefferies
The Oncology Institute initiated with a Buy at Jefferies
UTHR United Therapeutics
$266.76 /

+1.805 (+0.68%)

11/03/22 Wedbush
United Therapeutics price target raised to $305 from $250 at Wedbush
11/03/22 Oppenheimer
United Therapeutics price target raised to $375 from $325 at Oppenheimer
11/03/22 H.C. Wainwright
United Therapeutics price target raised to $300 from $255 at H.C. Wainwright
10/11/22 Morgan Stanley
United Therapeutics initiated with an Overweight at Morgan Stanley
CCRN Cross Country Healthcare
$33.47 /

+1.05 (+3.24%)

11/07/22 Barrington
Cross Country Healthcare price target raised to $45 from $41 at Barrington
10/05/22 Truist
Cross Country Healthcare downgraded to Hold at Truist on valuation
10/05/22 Truist
Cross Country Healthcare downgraded to Hold from Buy at Truist
09/15/22 Benchmark
Cross Country Healthcare price target raised to $42 from $37 at Benchmark
FULC Fulcrum Therapeutics
$5.61 /

-0.145 (-2.52%)

10/20/22 Stifel
Fulcrum Therapeutics price target lowered to $35 from $43 at Stifel
06/10/22 Piper Sandler
Fulcrum should be bought on today's selloff, says Piper Sandler
06/10/22 H.C. Wainwright
H.C. Wainwright says Fulcrum data 'raises multiple questions,' halves target
06/10/22 Oppenheimer
FTX-6058 benefits outweigh unresolved answers, says Oppenheimer
CADL Candel Therapeutics
$1.74 /

+0.17 (+10.86%)

03/31/22 BMO Capital
Candel Therapeutics price target lowered to $12 from $18 at BMO Capital
11/18/21 BMO Capital
Candel Therapeutics initiated with an Outperform at BMO Capital
BIO Bio-Rad
$378.95 /

+1.42 (+0.38%)

10/11/22 Jefferies
Jefferies 'not surprised' by report of Bio-Rad talks to combine with Qiagen
08/24/22 Credit Suisse
Bio-Rad initiated with an Outperform at Credit Suisse
07/08/22 Citi
Bio-Rad price target lowered to $700 from $750 at Citi
05/02/22 Citi
Bio-Rad price target lowered to $750 from $800 at Citi
AMWL Amwell
$3.64 /

+0.025 (+0.69%)

09/07/22 Truist
Amwell initiated with a Hold at Truist
09/07/22 Piper Sandler
Amwell price target lowered to $5 from $6 at Piper Sandler
06/23/22 Piper Sandler
Amwell price target raised to $6 from $5 at Piper Sandler
06/03/22 Morgan Stanley
CVS deal a 'game-changer' for Amwell's Converge, says Morgan Stanley
CGEM Cullinan Oncology
$12.22 /

-0.2 (-1.61%)

GLUE Monte Rosa Therapeutics
$8.24 /

+0.015 (+0.18%)

10/13/22 UBS
Monte Rosa Therapeutics initiated with a Buy at UBS
08/15/22 Jefferies
Monte Rosa Therapeutics initiated with a Buy at Jefferies
05/11/22 Piper Sandler
Monte Rosa Therapeutics price target lowered to $21 from $40 at Piper Sandler
04/28/22 Credit Suisse
Monte Rosa Therapeutics initiated with a Neutral at Credit Suisse
UTHR United Therapeutics
$266.76 /

+1.805 (+0.68%)

TOI The Oncology Institute
$3.27 /

-0.095 (-2.83%)

TNDM TNDM
/

+

THC Tenet Healthcare
$41.06 /

-0.7 (-1.68%)

STRO Sutro Biopharma
$7.52 /

+0.17 (+2.31%)

ROIV Roivant Sciences
$5.62 /

+0.12 (+2.18%)

RNA Avidity Biosciences
$13.24 /

-0.305 (-2.25%)

MGTA Magenta Therapeutics
$1.21 /

+0.01 (+0.83%)

KMDA Kamada
$4.33 /

-0.05 (-1.14%)

JNJ Johnson & Johnson
$173.05 /

+1.74 (+1.02%)

IQV Iqvia
$207.99 /

+3.96 (+1.94%)

GLUE Monte Rosa Therapeutics
$8.24 /

+0.015 (+0.18%)

FULC Fulcrum Therapeutics
$5.61 /

-0.145 (-2.52%)

CYH Community Health
$2.93 /

-0.015 (-0.51%)

CGEM Cullinan Oncology
$12.22 /

-0.2 (-1.61%)

CCRN Cross Country Healthcare
$33.47 /

+1.05 (+3.24%)

CADL Candel Therapeutics
$1.74 /

+0.17 (+10.86%)

BIO Bio-Rad
$378.95 /

+1.42 (+0.38%)

AMWL Amwell
$3.64 /

+0.025 (+0.69%)

ABSI Absci
$2.98 /

+0.07 (+2.41%)

  • 16
    Aug
  • 30
    Nov
JNJ Johnson & Johnson
$173.05 /

+1.74 (+1.02%)

IQV Iqvia
$207.99 /

+3.96 (+1.94%)

CYH Community Health
$2.93 /

-0.015 (-0.51%)

BIO Bio-Rad
$378.95 /

+1.42 (+0.38%)

AMWL Amwell
$3.64 /

+0.025 (+0.69%)

UTHR United Therapeutics
$266.76 /

+1.805 (+0.68%)

TOI The Oncology Institute
$3.27 /

-0.095 (-2.83%)

TNDM TNDM
/

+

THC Tenet Healthcare
$41.06 /

-0.7 (-1.68%)

STRO Sutro Biopharma
$7.52 /

+0.17 (+2.31%)

ROIV Roivant Sciences
$5.62 /

+0.12 (+2.18%)

RNA Avidity Biosciences
$13.24 /

-0.305 (-2.25%)

KMDA Kamada
$4.33 /

-0.05 (-1.14%)

JNJ Johnson & Johnson
$173.05 /

+1.74 (+1.02%)

FULC Fulcrum Therapeutics
$5.61 /

-0.145 (-2.52%)

CYH Community Health
$2.93 /

-0.015 (-0.51%)

CGEM Cullinan Oncology
$12.22 /

-0.2 (-1.61%)

CCRN Cross Country Healthcare
$33.47 /

+1.05 (+3.24%)

BIO Bio-Rad
$378.95 /

+1.42 (+0.38%)

AMWL Amwell
$3.64 /

+0.025 (+0.69%)

THC Tenet Healthcare
$41.06 /

-0.7 (-1.68%)

JNJ Johnson & Johnson
$173.05 /

+1.74 (+1.02%)

IQV Iqvia
$207.99 /

+3.96 (+1.94%)

GLUE Monte Rosa Therapeutics
$8.24 /

+0.015 (+0.18%)

Conference/Events
Credit Suisse to hold a conference » 23:32
11/07/22
11/07
23:32
11/07/22
23:32
ABSI

Absci

$2.98 /

+0.07 (+2.41%)

, CYH

Community Health

$2.93 /

-0.015 (-0.51%)

, IQV

Iqvia

$207.99 /

+3.96 (+1.94%)

, RNA

Avidity Biosciences

$13.24 /

-0.305 (-2.25%)

, ROIV

Roivant Sciences

$5.62 /

+0.12 (+2.18%)

, JNJ

Johnson & Johnson

$173.05 /

+1.74 (+1.02%)

, KMDA

Kamada

$4.33 /

-0.05 (-1.14%)

, MGTA

Magenta Therapeutics

$1.21 /

+0.01 (+0.83%)

, STRO

Sutro Biopharma

$7.52 /

+0.17 (+2.31%)

, THC

Tenet Healthcare

$41.06 /

-0.7 (-1.68%)

, TNDM

TNDM

/

+

, TOI

The Oncology Institute

$3.27 /

-0.095 (-2.83%)

, UTHR

United Therapeutics

$266.76 /

+1.805 (+0.68%)

, CCRN

Cross Country Healthcare

$33.47 /

+1.05 (+3.24%)

, FULC

Fulcrum Therapeutics

$5.61 /

-0.145 (-2.52%)

, CADL

Candel Therapeutics

$1.74 /

+0.17 (+10.86%)

, BIO

Bio-Rad

$378.95 /

+1.42 (+0.38%)

, AMWL

Amwell

$3.64 /

+0.025 (+0.69%)

, CGEM

Cullinan Oncology

$12.22 /

-0.2 (-1.61%)

, GLUE

Monte Rosa Therapeutics

$8.24 /

+0.015 (+0.18%)

31st Annual Healthcare…

31st Annual Healthcare Conference to be held in Rancho Palos Verdes, CA on November 7-10.

ShowHide Related Items >><<
UTHR United Therapeutics
$266.76 /

+1.805 (+0.68%)

TOI The Oncology Institute
$3.27 /

-0.095 (-2.83%)

TNDM TNDM
/

+

THC Tenet Healthcare
$41.06 /

-0.7 (-1.68%)

STRO Sutro Biopharma
$7.52 /

+0.17 (+2.31%)

ROIV Roivant Sciences
$5.62 /

+0.12 (+2.18%)

RNA Avidity Biosciences
$13.24 /

-0.305 (-2.25%)

MGTA Magenta Therapeutics
$1.21 /

+0.01 (+0.83%)

KMDA Kamada
$4.33 /

-0.05 (-1.14%)

JNJ Johnson & Johnson
$173.05 /

+1.74 (+1.02%)

IQV Iqvia
$207.99 /

+3.96 (+1.94%)

GLUE Monte Rosa Therapeutics
$8.24 /

+0.015 (+0.18%)

FULC Fulcrum Therapeutics
$5.61 /

-0.145 (-2.52%)

CYH Community Health
$2.93 /

-0.015 (-0.51%)

CGEM Cullinan Oncology
$12.22 /

-0.2 (-1.61%)

CCRN Cross Country Healthcare
$33.47 /

+1.05 (+3.24%)

CADL Candel Therapeutics
$1.74 /

+0.17 (+10.86%)

BIO Bio-Rad
$378.95 /

+1.42 (+0.38%)

AMWL Amwell
$3.64 /

+0.025 (+0.69%)

ABSI Absci
$2.98 /

+0.07 (+2.41%)

ABSI Absci
$2.98 /

+0.07 (+2.41%)

08/12/22 JPMorgan
Absci double downgraded to Underweight at JPMorgan on slower revenue ramp
08/12/22 JPMorgan
Absci downgraded to Underweight from Overweight at JPMorgan
08/12/22 Cowen
Absci upgraded to Outperform from Market Perform at Cowen
07/18/22 Truist
Truist starts Absci at Buy on confluence of biotech, next-gen biologics
CYH Community Health
$2.93 /

-0.015 (-0.51%)

08/04/22 Citi
Community Health price target lowered to $6 from $14 at Citi
07/29/22 Oppenheimer
Community Health price target lowered to $6 from $16 at Oppenheimer
06/16/22 Loop Capital
Loop starts Community Health at Hold amid labor challenges
06/16/22 Loop Capital
Community Health initiated with a Hold at Loop Capital
IQV Iqvia
$207.99 /

+3.96 (+1.94%)

10/27/22 Credit Suisse
Iqvia price target lowered to $265 from $300 at Credit Suisse
10/27/22 Citi
Iqvia price target lowered to $275 from $290 at Citi
10/27/22 Barclays
Iqvia price target raised to $235 from $215 at Barclays
10/18/22 Deutsche Bank
Iqvia price target lowered to $270 from $290 at Deutsche Bank
RNA Avidity Biosciences
$13.24 /

-0.305 (-2.25%)

09/27/22 Chardan
Avidity Biosciences price target lowered to $27 from $29 at Chardan
07/20/22 Chardan
Avidity Biosciences initiated with a Buy at Chardan
07/11/22 Raymond James
Avidity Biosciences initiated with a Strong Buy at Raymond James
ROIV Roivant Sciences
$5.62 /

+0.12 (+2.18%)

10/27/22 JPMorgan
Roivant Sciences initiated with an Overweight at JPMorgan
08/16/22 Citi
Roivant Sciences price target raised to $10 from $9 at Citi
05/23/22 SVB Securities
Roivant Sciences initiated with an Outperform at SVB Leerink
04/29/22 Cantor Fitzgerald
Roivant Sciences initiated with an Overweight at Cantor Fitzgerald
JNJ Johnson & Johnson
$173.05 /

+1.74 (+1.02%)

11/02/22 Morgan Stanley
Abiomed upgraded to Equal Weight from Underweight at Morgan Stanley
11/02/22 Deutsche Bank
Abiomed downgraded to Hold from Buy at Deutsche Bank
11/01/22 Piper Sandler
Abiomed downgraded to Neutral from Overweight at Piper Sandler
11/01/22 Cowen
Cowen starts Legend Biotech with an Outperform on Carvykti potential
KMDA Kamada
$4.33 /

-0.05 (-1.14%)

MGTA Magenta Therapeutics
$1.21 /

+0.01 (+0.83%)

08/24/22 Goldman Sachs
Magenta downgraded on limited clinical catalysts at Goldman Sachs
08/24/22 Goldman Sachs
Magenta Therapeutics downgraded to Neutral from Buy at Goldman Sachs
04/18/22 Mizuho
Magenta Therapeutics price target lowered to $8 from $17 at Mizuho
04/18/22 BTIG
Magenta Therapeutics price target lowered to $6 from $10 at BTIG
STRO Sutro Biopharma
$7.52 /

+0.17 (+2.31%)

08/23/22 Truist
Sutro Biopharma price target lowered to $21 from $37 at Truist
08/18/22 Wells Fargo
Sutro Biopharma assumed with an Overweight at Wells Fargo
06/28/22 Piper Sandler
Sutro Biopharma price target raised to $16 from $14 at Piper Sandler
05/23/22 Piper Sandler
Sutro Biopharma price target lowered to $14 from $29 at Piper Sandler
THC Tenet Healthcare
$41.06 /

-0.7 (-1.68%)

10/27/22 Raymond James
Tenet Healthcare price target lowered to $80 from $135 at Raymond James
10/25/22 Citi
Tenet Healthcare shares offer 'significant upside,' says Citi
10/24/22 Truist
Tenet Healthcare price target lowered to $55 from $80 at Truist
10/24/22 Deutsche Bank
Tenet Healthcare price target lowered to $48 from $90 at Deutsche Bank
TNDM TNDM
/

+

11/03/22 Lake Street
Tandem Diabetes price target lowered to $60 from $150 at Lake Street
11/03/22 Craig-Hallum
Tandem Diabetes price target lowered to $80 from $105 at Craig-Hallum
11/03/22 Cowen
Tandem Diabetes price target lowered to $61 from $107 at Cowen
11/03/22 Baird
Tandem Diabetes price target lowered to $45 from $76 at Baird
TOI The Oncology Institute
$3.27 /

-0.095 (-2.83%)

09/14/22 Guggenheim
The Oncology Institute initiated with a Buy at Guggenheim
08/15/22 Jefferies
The Oncology Institute initiated with a Buy at Jefferies
UTHR United Therapeutics
$266.76 /

+1.805 (+0.68%)

11/03/22 Wedbush
United Therapeutics price target raised to $305 from $250 at Wedbush
11/03/22 Oppenheimer
United Therapeutics price target raised to $375 from $325 at Oppenheimer
11/03/22 H.C. Wainwright
United Therapeutics price target raised to $300 from $255 at H.C. Wainwright
10/11/22 Morgan Stanley
United Therapeutics initiated with an Overweight at Morgan Stanley
CCRN Cross Country Healthcare
$33.47 /

+1.05 (+3.24%)

11/07/22 Barrington
Cross Country Healthcare price target raised to $45 from $41 at Barrington
10/05/22 Truist
Cross Country Healthcare downgraded to Hold at Truist on valuation
10/05/22 Truist
Cross Country Healthcare downgraded to Hold from Buy at Truist
09/15/22 Benchmark
Cross Country Healthcare price target raised to $42 from $37 at Benchmark
FULC Fulcrum Therapeutics
$5.61 /

-0.145 (-2.52%)

10/20/22 Stifel
Fulcrum Therapeutics price target lowered to $35 from $43 at Stifel
06/10/22 Piper Sandler
Fulcrum should be bought on today's selloff, says Piper Sandler
06/10/22 H.C. Wainwright
H.C. Wainwright says Fulcrum data 'raises multiple questions,' halves target
06/10/22 Oppenheimer
FTX-6058 benefits outweigh unresolved answers, says Oppenheimer
CADL Candel Therapeutics
$1.74 /

+0.17 (+10.86%)

03/31/22 BMO Capital
Candel Therapeutics price target lowered to $12 from $18 at BMO Capital
11/18/21 BMO Capital
Candel Therapeutics initiated with an Outperform at BMO Capital
BIO Bio-Rad
$378.95 /

+1.42 (+0.38%)

10/11/22 Jefferies
Jefferies 'not surprised' by report of Bio-Rad talks to combine with Qiagen
08/24/22 Credit Suisse
Bio-Rad initiated with an Outperform at Credit Suisse
07/08/22 Citi
Bio-Rad price target lowered to $700 from $750 at Citi
05/02/22 Citi
Bio-Rad price target lowered to $750 from $800 at Citi
AMWL Amwell
$3.64 /

+0.025 (+0.69%)

09/07/22 Truist
Amwell initiated with a Hold at Truist
09/07/22 Piper Sandler
Amwell price target lowered to $5 from $6 at Piper Sandler
06/23/22 Piper Sandler
Amwell price target raised to $6 from $5 at Piper Sandler
06/03/22 Morgan Stanley
CVS deal a 'game-changer' for Amwell's Converge, says Morgan Stanley
CGEM Cullinan Oncology
$12.22 /

-0.2 (-1.61%)

GLUE Monte Rosa Therapeutics
$8.24 /

+0.015 (+0.18%)

10/13/22 UBS
Monte Rosa Therapeutics initiated with a Buy at UBS
08/15/22 Jefferies
Monte Rosa Therapeutics initiated with a Buy at Jefferies
05/11/22 Piper Sandler
Monte Rosa Therapeutics price target lowered to $21 from $40 at Piper Sandler
04/28/22 Credit Suisse
Monte Rosa Therapeutics initiated with a Neutral at Credit Suisse
UTHR United Therapeutics
$266.76 /

+1.805 (+0.68%)

TOI The Oncology Institute
$3.27 /

-0.095 (-2.83%)

TNDM TNDM
/

+

THC Tenet Healthcare
$41.06 /

-0.7 (-1.68%)

STRO Sutro Biopharma
$7.52 /

+0.17 (+2.31%)

ROIV Roivant Sciences
$5.62 /

+0.12 (+2.18%)

RNA Avidity Biosciences
$13.24 /

-0.305 (-2.25%)

MGTA Magenta Therapeutics
$1.21 /

+0.01 (+0.83%)

KMDA Kamada
$4.33 /

-0.05 (-1.14%)

JNJ Johnson & Johnson
$173.05 /

+1.74 (+1.02%)

IQV Iqvia
$207.99 /

+3.96 (+1.94%)

GLUE Monte Rosa Therapeutics
$8.24 /

+0.015 (+0.18%)

FULC Fulcrum Therapeutics
$5.61 /

-0.145 (-2.52%)

CYH Community Health
$2.93 /

-0.015 (-0.51%)

CGEM Cullinan Oncology
$12.22 /

-0.2 (-1.61%)

CCRN Cross Country Healthcare
$33.47 /

+1.05 (+3.24%)

CADL Candel Therapeutics
$1.74 /

+0.17 (+10.86%)

BIO Bio-Rad
$378.95 /

+1.42 (+0.38%)

AMWL Amwell
$3.64 /

+0.025 (+0.69%)

ABSI Absci
$2.98 /

+0.07 (+2.41%)

  • 16
    Aug
  • 30
    Nov
JNJ Johnson & Johnson
$173.05 /

+1.74 (+1.02%)

IQV Iqvia
$207.99 /

+3.96 (+1.94%)

CYH Community Health
$2.93 /

-0.015 (-0.51%)

BIO Bio-Rad
$378.95 /

+1.42 (+0.38%)

AMWL Amwell
$3.64 /

+0.025 (+0.69%)

UTHR United Therapeutics
$266.76 /

+1.805 (+0.68%)

TOI The Oncology Institute
$3.27 /

-0.095 (-2.83%)

TNDM TNDM
/

+

THC Tenet Healthcare
$41.06 /

-0.7 (-1.68%)

STRO Sutro Biopharma
$7.52 /

+0.17 (+2.31%)

ROIV Roivant Sciences
$5.62 /

+0.12 (+2.18%)

RNA Avidity Biosciences
$13.24 /

-0.305 (-2.25%)

KMDA Kamada
$4.33 /

-0.05 (-1.14%)

JNJ Johnson & Johnson
$173.05 /

+1.74 (+1.02%)

FULC Fulcrum Therapeutics
$5.61 /

-0.145 (-2.52%)

CYH Community Health
$2.93 /

-0.015 (-0.51%)

CGEM Cullinan Oncology
$12.22 /

-0.2 (-1.61%)

CCRN Cross Country Healthcare
$33.47 /

+1.05 (+3.24%)

BIO Bio-Rad
$378.95 /

+1.42 (+0.38%)

AMWL Amwell
$3.64 /

+0.025 (+0.69%)

THC Tenet Healthcare
$41.06 /

-0.7 (-1.68%)

JNJ Johnson & Johnson
$173.05 /

+1.74 (+1.02%)

IQV Iqvia
$207.99 /

+3.96 (+1.94%)

GLUE Monte Rosa Therapeutics
$8.24 /

+0.015 (+0.18%)

Recommendations
Cross Country Healthcare price target raised to $45 from $41 at Barrington » 09:11
11/07/22
11/07
09:11
11/07/22
09:11
CCRN

Cross Country Healthcare

$32.48 /

-4.3 (-11.69%)

Barrington analyst Kevin…

Barrington analyst Kevin Steinke raised the firm's price target on Cross Country Healthcare to $45 from $41 and keeps an Outperform rating on the shares. The analyst notes the company's Q3/2022 results exceed recently increased guidance. The demand environment remains favorable due to the extremely tight healthcare labor market, Steinke adds, pointing out that growth also continues to benefit from the significant investments that Cross Country has made in recruiter productivity and capacity.

ShowHide Related Items >><<
CCRN Cross Country Healthcare
$32.48 /

-4.3 (-11.69%)

CCRN Cross Country Healthcare
$32.48 /

-4.3 (-11.69%)

10/05/22 Truist
Cross Country Healthcare downgraded to Hold at Truist on valuation
10/05/22 Truist
Cross Country Healthcare downgraded to Hold from Buy at Truist
09/15/22 Benchmark
Cross Country Healthcare price target raised to $42 from $37 at Benchmark
06/17/22 Barrington
Cross Country Healthcare shares 'significantly undervalued,' says Barrington
CCRN Cross Country Healthcare
$32.48 /

-4.3 (-11.69%)

CCRN Cross Country Healthcare
$32.48 /

-4.3 (-11.69%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.